Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy

Several attempts have been made over the past decade to explore the concept of prodrug strategies that exploit PSA as a molecular target for the release of anticancer drugs in prostate tumors using various prostate specific antigen (PSA)-cleavable peptide linkers, but the desired antitumor and antim...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsadek, Bakheet E.M., Hassan, Mohammed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933701/
https://www.ncbi.nlm.nih.gov/pubmed/33718631
http://dx.doi.org/10.1016/j.bbrep.2021.100966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933701/
https://www.ncbi.nlm.nih.gov/pubmed/33718631
http://dx.doi.org/10.1016/j.bbrep.2021.100966

Ejemplares similares